NO20005250D0 - Kontrastmiddel - Google Patents

Kontrastmiddel

Info

Publication number
NO20005250D0
NO20005250D0 NO20005250A NO20005250A NO20005250D0 NO 20005250 D0 NO20005250 D0 NO 20005250D0 NO 20005250 A NO20005250 A NO 20005250A NO 20005250 A NO20005250 A NO 20005250A NO 20005250 D0 NO20005250 D0 NO 20005250D0
Authority
NO
Norway
Prior art keywords
dispersed
gas
preparations
perfusion
material present
Prior art date
Application number
NO20005250A
Other languages
English (en)
Other versions
NO20005250L (no
Inventor
Morten Eriksen
Helge Tolleshaug
Roald Skurtveit
Alan Cuthbertson
Jonny Istensen
Sigmund Frigstad
Pol Rongved
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO20005250D0 publication Critical patent/NO20005250D0/no
Publication of NO20005250L publication Critical patent/NO20005250L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005250A 1998-04-22 2000-10-19 Kontrastmiddel NO20005250L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents
PCT/GB1999/001221 WO1999053963A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents

Publications (2)

Publication Number Publication Date
NO20005250D0 true NO20005250D0 (no) 2000-10-19
NO20005250L NO20005250L (no) 2000-12-18

Family

ID=10830802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005250A NO20005250L (no) 1998-04-22 2000-10-19 Kontrastmiddel

Country Status (17)

Country Link
US (1) US20040146462A1 (no)
EP (1) EP1073473B1 (no)
JP (1) JP2002512206A (no)
KR (1) KR20010042915A (no)
CN (1) CN1306442A (no)
AT (1) ATE375806T1 (no)
AU (1) AU3617299A (no)
BR (1) BR9909822A (no)
CA (1) CA2329175A1 (no)
DE (1) DE69937341D1 (no)
GB (1) GB9808599D0 (no)
HU (1) HUP0102878A3 (no)
IL (1) IL139147A0 (no)
NO (1) NO20005250L (no)
PL (1) PL343464A1 (no)
WO (1) WO1999053963A1 (no)
ZA (1) ZA200005789B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
AU2003302593B2 (en) 2002-11-29 2007-02-01 Ge Healthcare As Ultrasound triggering method
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
CA2512454C (en) 2003-02-04 2012-10-30 Bracco Research Sa Ultrasound contrast agents and process for the preparation thereof
CA2545362C (en) * 2003-12-22 2013-02-12 Bracco Research Sa Assembly of gas-filled microvesicle with active component for contrast imaging
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
EP1784228B1 (en) 2004-08-18 2016-10-05 Bracco Suisse SA Gas-filled microvesicles composition for contrast imaging
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
US20080255266A1 (en) * 2007-04-10 2008-10-16 Gc Corporation Dental paste composition having x-ray imaging property
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
US20110158909A1 (en) * 2008-02-01 2011-06-30 Trustees Of Boston University Cationic Contrast Agents and Methods of Use Thereof
CA2723171C (en) * 2008-05-02 2018-03-27 Celsense, Inc. Emulsion compositions and methods for nuclear magnetic resonance and other imaging
EP2470287A4 (en) 2009-08-28 2015-01-21 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR PRODUCING GAS-FILLED MICROBUBBLES
DE102011005444A1 (de) * 2011-03-11 2012-09-13 Innora Gmbh Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes
WO2015047103A1 (en) 2013-09-27 2015-04-02 Phoenix Solutions As Ultrasound mediated delivery of drugs
JOP20200052A1 (ar) * 2013-12-19 2017-06-16 Bayer Pharma AG بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c
DE112018003501T5 (de) * 2017-07-09 2020-04-23 The Board Of Trustees Of The Leland Stanford Junior University Ultraschallbildgebung mit spektraler compoundierung zur speckle-reduzierung
CN108586300B (zh) * 2018-03-28 2020-03-17 成都福柯斯医药技术有限公司 一种s-碘化丁酰硫代胆碱的合成方法
CN114760989A (zh) 2019-10-25 2022-07-15 精准医疗股份有限公司 胰腺癌的治疗
GB2595513B (en) 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
US11801058B2 (en) * 2021-03-04 2023-10-31 Accumedical Beijing Ltd. Liquid embolic compositions
GB2605422A (en) 2021-03-31 2022-10-05 Act Therapeutics Ltd Treatment of the central nervous system
GB2605996A (en) 2021-04-21 2022-10-26 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
EP4261786A1 (en) * 2022-03-28 2023-10-18 Tata Consultancy Services Limited Methods and system for low dose x ray computed tomography perfusion imaging

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
CA2164813C (en) * 1993-07-30 2009-11-24 Ernest G. Schutt Stabilized microbubble compositions for ultrasound
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
AP885A (en) * 1996-10-21 2000-11-03 Nycomed Imaging As Ultrasonic visualisation using a gas containing contrast agent.
ES2206689T3 (es) * 1996-10-28 2004-05-16 Amersham Health As Agentes de contraste.
WO1998018498A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) * 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents

Also Published As

Publication number Publication date
CA2329175A1 (en) 1999-10-28
KR20010042915A (ko) 2001-05-25
ATE375806T1 (de) 2007-11-15
WO1999053963A1 (en) 1999-10-28
AU3617299A (en) 1999-11-08
JP2002512206A (ja) 2002-04-23
CN1306442A (zh) 2001-08-01
GB9808599D0 (en) 1998-06-24
BR9909822A (pt) 2000-12-19
EP1073473B1 (en) 2007-10-17
ZA200005789B (en) 2001-07-30
HUP0102878A3 (en) 2002-12-28
EP1073473A1 (en) 2001-02-07
DE69937341D1 (de) 2007-11-29
IL139147A0 (en) 2001-11-25
PL343464A1 (en) 2001-08-13
HUP0102878A2 (hu) 2002-03-28
US20040146462A1 (en) 2004-07-29
NO20005250L (no) 2000-12-18

Similar Documents

Publication Publication Date Title
NO20005250L (no) Kontrastmiddel
WO1998017324A3 (en) Improvements in or relating to contrast agents
SE9503143D0 (sv) New preparation
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
NO20031249D0 (no) Emulsjonspreparater samt konsentrater derav
DE69105106T2 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
ECSP045496A (es) "preparaciones acidas de insulina con estabilidad mejorada"
RU94033520A (ru) Впрыскиваемый лецитиновый гель
BRPI0414128A (pt) sistema e método para aumento de mamas
CA2383600A1 (en) Method for determining viability of a myocardial segment
US6811766B1 (en) Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
HRP20120165T1 (hr) Novi pripravci na bazi taksoida
SE9402880D0 (sv) New peptide derivatives
Sugiyama et al. Histamine-release induced by 7s nervegrowth factor of mouse submandibular salivary glands
JP2001515053A (ja) 造影剤におけるまたは造影剤に関する改良
GB9808582D0 (en) Improvements in or relating to contrast agents
Møller et al. Neurohumoral fluid regulation in chronic liver disease
EA200101106A1 (ru) Фармацевтический комплекс
WO2003072606A3 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
KR900017599A (ko) 종양 치료용 약학 조성물
JPH0314522A (ja) 化学・免疫学的抗癌物質製剤
Soloviev et al. Platelet-activating factor (PAF) induces contraction of saponin-skinned smooth muscle of coronary artery
Kolitz Immunofluorescent characterization of collagen types I and III in normal saphenous veins and aortocoronary saphenous vein grafts
FI991115A0 (fi) Menetelmä oraalisesti elimistöön tuotavan ravinteen tai muun fysiologisesti vaikuttavan aineen maittavuuden biokyberneettiseksi manipuloimiseksi sekä menetelmän käyttämiseen liittyvä valmiste
AR027614A2 (es) Compuesto de purina l-nucleosido, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application